What is ReliaLab Test?
ReliaLab Test operates as a specialized medical laboratory providing a comprehensive suite of diagnostic services, including drug, alcohol, and DNA testing. The company distinguishes itself through a dual-market approach, catering to the rigorous requirements of corporate wellness programs and background checks while simultaneously offering accessible, high-precision testing for individual consumers. Their service portfolio, which encompasses complex procedures such as prenatal DNA testing and advanced hair follicle drug screening, positions them as a critical infrastructure provider in the Nashville region and across the national landscape. By prioritizing security, accuracy, and rapid turnaround times, ReliaLab Test has established a defensible market position as a reliable partner for employers seeking regulatory compliance and individuals requiring sensitive diagnostic data.
How much funding has ReliaLab Test raised?
ReliaLab Test has raised a total of $31K across 1 funding round:
Debt
$31K
Debt (2021): $31K with participation from PPP
Key Investors in ReliaLab Test
PPP
Public-Private Partnership
What's next for ReliaLab Test?
With the recent infusion of capital, ReliaLab Test is poised to enter a new phase of strategic scaling. The company is expected to focus on enhancing its laboratory automation and digital reporting platforms to meet the increasing demand for secure, real-time diagnostic results. Furthermore, the firm will likely prioritize the expansion of its corporate wellness footprint, leveraging its existing reputation for reliability to capture a larger share of the national employer-sponsored testing market. As the company matures through its current growth stage, the focus will shift toward optimizing operational efficiencies and potentially diversifying its diagnostic offerings to include emerging health screening technologies, thereby solidifying its long-term viability in the healthcare services sector.
See full ReliaLab Test company page
